4.3 Article

Inhibition of circ_0004381 improves cognitive function via miR-647/PSEN1 axis in an Alzheimer disease mouse model

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset

Dieter Petit et al.

Summary: This study provides a comprehensive analysis of Aβ profiles in familial Alzheimer's disease and reveals a linear correlation between mutation-driven alterations in Aβ profiles and early age at onset. The study also identifies the predictive value of the Aβ (37 + 38 + 40) / (42 + 43) ratio in assessing "unclear" PSEN1 variants.

MOLECULAR PSYCHIATRY (2022)

Article Biochemistry & Molecular Biology

CircAXL Knockdown Alleviates Aβ1-42-Induced Neurotoxicity in Alzheimer's Disease via Repressing PDE4A by Releasing miR-1306-5p

Shengxi Meng et al.

Summary: This study found that circAXL plays an important role in the development of Alzheimer's disease. Knockdown of circAXL can alleviate cell cytotoxicity, cell apoptosis, inflammation, oxidative stress, and endoplasmic reticulum stress in AD pathology.

NEUROCHEMICAL RESEARCH (2022)

Article Neurosciences

Circular RNA hsa_circ_0004381 Promotes Neuronal Injury in Parkinson's Disease Cell Model by miR-185-5p/RAC1 Axis

Hongying Zhang et al.

Summary: This study explores the molecular mechanism in Parkinson's disease (PD) and finds that Hsa_circ_0004381 regulates MPP+-induced neuronal injury through the miR-185-5p/RAC1 axis.

NEUROTOXICITY RESEARCH (2022)

Article Oncology

Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p

Haixia Li et al.

Summary: The study demonstrated that Mex3a plays a significant role in colorectal cancer (CRC) by regulating the RAP1GAP/MEK/ERK/HIF-1α pathway. Mex3a was identified as a prognostic factor for overall survival in CRC patients, and knockdown of Mex3a inhibited tumor cell migration, invasion, and proliferation. Furthermore, hsa-miR-6887-3p was found to downregulate Mex3a expression and inhibit CRC tumorigenesis both in vitro and in vivo.

CANCER COMMUNICATIONS (2021)

Review Geriatrics & Gerontology

Microglia Polarization in Alzheimer's Disease: Mechanisms and a Potential Therapeutic Target

Qinqin Wang et al.

Summary: Microglia regulated neuroinflammation plays an important role in the pathogenesis of Alzheimer's disease (AD). M1 and M2 microglia have pro-inflammatory and anti-inflammatory effects, respectively, in AD. Aβ and hyperphosphorylated tau are implicated in microglial activation and subsequent inflammation, contributing to neuronal and synaptic loss in AD.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Multidisciplinary Sciences

miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer's disease

Kai Zheng et al.

Summary: Dysfunction of miR-135a-5p/Rock2/Add1 in excitatory hippocampal neurons has been linked to memory/synaptic disorders in a mouse model of Alzheimer's disease. The downregulation of miR-135a-5p in AD mice and subsequent excess Rock2 levels play a critical role in synaptic impairments, offering a potential therapeutic target for AD. Various miRNAs have been found to be deregulated in individuals with Alzheimer's disease, highlighting the importance of studying the role of miRNAs in AD pathology.

NATURE COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease

Teeba Athar et al.

Summary: Alzheimer's disease is a complex, multifactorial, and progressive neurodegenerative disease with currently limited treatment options. Despite global efforts to identify new therapeutic agents, only one drug has been approved by the FDA for the treatment of AD since 2003. Further research is needed to develop novel therapeutic strategies to combat this century-old disease.

MOLECULAR BIOLOGY REPORTS (2021)

Review Geriatrics & Gerontology

The Emerging Role of Circular RNAs in Alzheimer's Disease and Parkinson's Disease

Meng Zhang et al.

Summary: Studies suggest that circRNAs could serve as promising biomarkers for early diagnosis of NDDs, such as AD and PD, and may lead to new therapeutic approaches targeting transcription for preventing neurodegeneration.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Medicine, Research & Experimental

Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function

Jihoon Han et al.

Summary: The five FAD-linked PS1 mutations have been shown to have deleterious effects on mitochondrial functions in different ways. Each PS1 mutant affected mitochondrial morphology and function differently, with some inducing mitochondrial fragmentation while others increased MAMs formation and oxidative stress. These mutations compromised mitochondrial membrane potential and ATP production, which may contribute to an accelerated age of disease onset in individuals with mutant PS1.

THERANOSTICS (2021)

Article Biotechnology & Applied Microbiology

miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9

Kun Qin et al.

JOURNAL OF GENE MEDICINE (2020)

Review Neurosciences

Role of circular RNAs in brain development and CNS diseases

Suresh L. Mehta et al.

PROGRESS IN NEUROBIOLOGY (2020)

Review Cell Biology

Functional roles of circular RNAs in Alzheimer's disease

Jin-Lan Huang et al.

AGEING RESEARCH REVIEWS (2020)

Review Neurosciences

Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes

Hyuk Sung Kwon et al.

TRANSLATIONAL NEURODEGENERATION (2020)

Review Pharmacology & Pharmacy

Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities

Judit M. Perez Ortiz et al.

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Review Medical Laboratory Technology

Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease

Tomris Ozben et al.

CLINICAL BIOCHEMISTRY (2019)

Article Genetics & Heredity

The association between apolipoprotein E and gallstone disease: an updated meta-analysis

Lizhuo Li et al.

BMC MEDICAL GENETICS (2019)

Review Clinical Neurology

Alzheimer's disease

C. A. Lane et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Psychiatry

Alzheimer's disease: clinical update on epidemiology, pathophysiology and diagnosis

Dhamidhu Eratne et al.

AUSTRALASIAN PSYCHIATRY (2018)

Review Biochemistry & Molecular Biology

γ-Secretase in microglia - implications for neurodegeneration and neuroinflammation

Jochen Walter et al.

JOURNAL OF NEUROCHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed

Agnieszka Rybak-Wolf et al.

MOLECULAR CELL (2015)

Review Biochemistry & Molecular Biology

Oxidative stress and mitochondrial dysfunction in Alzheimer's disease

Xinglong Wang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Editorial Material Immunology

MITOCHONDRIAL ALTERATIONS, OXIDATIVE STRESS AND NEUROINFLAMMATION IN ALZHEIMER'S DISEASE

M. Verri et al.

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2012)

Article Biochemistry & Molecular Biology

Presenilin 1:: more than just γ-secretase

T Raemaekers et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2005)